GlassScriptPhysician profile
Uma D Subedi
NPI 1255105680
$225.76
in general payments reported to CMS, 2019-2025
10 companies · $32.51 in 2025
The $32.51 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $193 · 2025: $32.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $40.79 | 2024 | Zilbrysq, Rystiggo |
| Neurelis, INC. | $28.26 | 2024 | Valtoco |
| Csl Behring | $25.89 | 2024 | Kcentra |
| Genentech USA, INC. | $24.51 | 2024 | Ocrevus, Enspryng |
| Jazz Pharmaceuticals INC. | $19.34 | 2024 | |
| Alexion Pharmaceuticals, INC. | $19.14 | 2024 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $18.85 | 2024 | Andexxa |
| Pfizer INC. | $17.25 | 2025 | |
| Argenx US, INC. | $16.47 | 2024 | Vyvgart |
| Penumbra, INC. | $15.26 | 2025 | Red 72 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uma Subedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.